|
PSMC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.09730000536135E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.56510000094113E-08 |
| Normal-vs-Stage2 |
3.566200E-02 |
| Normal-vs-Stage3 |
1.400760E-01 |
| Normal-vs-Stage4 |
3.561700E-03 |
| Stage1-vs-Stage2 |
1.604430E-01 |
| Stage1-vs-Stage3 |
7.558200E-03 |
| Stage1-vs-Stage4 |
7.108800E-01 |
| Stage2-vs-Stage3 |
4.080400E-01 |
| Stage2-vs-Stage4 |
5.972200E-01 |
| Stage3-vs-Stage4 |
2.044200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.54160000046078E-07 |
| Normal-vs-AfricanAmerican |
3.2089999999485E-06 |
| Normal-vs-Asian |
4.620700E-04 |
| Caucasian-vs-AfricanAmerican |
2.228600E-01 |
| Caucasian-vs-Asian |
5.833200E-01 |
| AfricanAmerican-vs-Asian |
9.164400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81889999950613E-07 |
| Normal-vs-Female |
1.58523000000077E-05 |
| Male-vs-Female |
6.230200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.595300E-04 |
| Normal-vs-Extreme_Weight |
5.4664999971088E-08 |
| Normal-vs-Obese |
2.821200E-04 |
| Normal-vs-Extreme_Obese |
3.228800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.211200E-01 |
| Normal_Weight-vs-Obese |
7.801600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.631800E-01 |
| Extreme_Weight-vs-Obese |
9.083200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.874640E-01 |
| Obese-vs-Extreme_Obese |
3.921800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.699400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.12570000002188E-06 |
| Normal-vs-Age(61-80Yrs) |
5.08069999960448E-07 |
| Normal-vs-Age(81-100Yrs) |
2.687400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.204000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.735000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.360000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.619400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.444600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.058600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.47242243239998E-12 |
| Normal-VS-Type2 PRCC |
1.384840E-01 |
| Normal-VS-KIRP CIMP |
3.038200E-01 |
| Normal-VS-Unclassified PRCC |
1.676550E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.02090000009269E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.534000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.076860E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.905400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.066400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.750200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.008100E-02 |
| Normal-vs-N1 |
2.736800E-03 |
| Normal-vs-N2 |
1.665170E-01 |
| N0-vs-N1 |
3.850400E-01 |
| N0-vs-N2 |
9.916400E-02 |
| N1-vs-N2 |
2.890100E-02 |
|
|
